Patents-Review.com
🔗 Permalink
Assignee profile:

APTEVO RESEARCH AND DEVELOPMENT LLC

City:

SEATTLE, Washington

Country:

United States

Published Applications:

13

Last publication date:

2024-10-17

Patent Grants:

12

Last grant date:

2025-10-14

Top Inventors for applications by APTEVO RESEARCH AND DEVELOPMENT LLC

These are the the leading inventors for applications assigned to APTEVO RESEARCH AND DEVELOPMENT LLC:

Recent patent applications by APTEVO RESEARCH AND DEVELOPMENT LLC

APTEVO RESEARCH AND DEVELOPMENT LLC based in SEATTLE, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-10-17 ✅ Patent 12,441,798 granted on 2025-10-14
US20240343801A1
Chemistry; metallurgy

CD123 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS

 #2 | 2022-11-17 ✅ Patent 11,939,392 granted on 2024-03-26
US20220363773A1
Chemistry; metallurgy

CD123 binding proteins and related compositions and methods

 #3 | 2020-05-28 ✅ Patent 11,242,400 granted on 2022-02-08
US20200165346A1
Chemistry; metallurgy

CD123 binding proteins and related compositions and methods

 #4 | 2019-12-19 ✅ Patent 11,312,786 granted on 2022-04-26
US20190382503A1
Chemistry; metallurgy

Oncofetal antigen binding proteins and related compositions and methods

 #5 | 2019-03-07 ✅ Patent 10,676,533 granted on 2020-06-09
US20190071513A1
Chemistry; metallurgy

Methods of treatment of CD123 overexpressing disorders

 #6 | 2019-01-17 ✅ Patent 10,239,949 granted on 2019-03-26
US20190016816A1
Chemistry; metallurgy

Oncofetal antigen binding proteins and related compositions and methods

 #7 | 2018-09-27 ✅ Patent 11,352,426 granted on 2022-06-07
US20180273622A1
Chemistry; metallurgy

CD3 binding polypeptides

 #8 | 2018-05-03
US20180118823A1
Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

 #9 | 2017-10-26 ✅ Patent 9,782,478 granted on 2017-10-10
US20170306045A1
Chemistry; metallurgy

Prostate-specific membrane antigen binding proteins and related compositions and methods

 #10 | 2015-08-20 ✅ Patent 10,202,452 granted on 2019-02-12
US20150232557A1
Chemistry; metallurgy

CD3 binding polypeptides

 #11 | 2014-01-02 ✅ Patent 10,143,748 granted on 2018-12-04
US20140004117A1
Chemistry; metallurgy

B-cell reduction using CD37-specific and CD20-specific binding molecules

 #12 | 2012-04-26 ✅ Patent 9,493,564 granted on 2016-11-15
US20120100139A1
Chemistry; metallurgy

CD86 antagonist multi-target binding proteins

 #13 | 2007-03-15 ✅ Patent 10,307,481 granted on 2019-06-04
US20070059306A1
Human necessities

CD37 immunotherapeutics and uses thereof

Also check out APTEVO RESEARCH AND DEVELOPMENT LLC's (Seattle, United States) applicant profile with 13 patent applications submitted.

AssigneeID:

134568 ⎘